{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:59:17Z","timestamp":1793206757678,"version":"4.5.0"},"reference-count":68,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Integr. Neurosci."],"abstract":"<jats:p>Continuous medical progress is significantly improving the quality of health care. As a result, people are living longer than during the past century, but this has also caused an increase of the prevalence of many neurological disorders. Parkinson\u2019s disease (PD) is the fastest growing neurological condition, with a doubling of cases reported between 1995 and 2015 and a further doubling projected by 2030. Parkinson\u2019s disease is generally associated with characteristic motor symptoms (resting tremor, rigidity, bradykinesia and postural instability). However, patients with PD also experience many non-motor symptoms that might be at least as debilitating as the motor symptoms and which significantly impact patients\u2019 quality of life (QoL). Pain is a frequent yet underrecognized symptom; the incidence in PD is much higher than in the general population and constitutes a silent disability that significantly contributes to a deterioration in QoL. Accurate identification of parkinsonian pain is important for its diagnosis and effective treatment. In this review, we provide an overview of the pathophysiology, classification, and management of pain in PD. We define the various modalities of chronic PD pain, suggesting possible explanations for its relationship with PD pathology, and discuss its management and currently recommended therapies.<\/jats:p>","DOI":"10.31083\/j.jin2205132","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T08:02:28Z","timestamp":1694160148000},"source":"Crossref","is-referenced-by-count":73,"title":["Pain in Parkinson's Disease: Pathophysiology, Classification and Treatment"],"prefix":"10.31083","volume":"22","author":[{"given":"Carlo","family":"Cattaneo","sequence":"first","affiliation":[{"name":"Medical Department, Zambon SpA, 20091 Bresso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Jost","sequence":"first","affiliation":[{"name":"Parkinson-Klinik Ortenau, 77709 Wolfach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Parkinson J. An essay on the shaking palsy. 1817. The Journal of Neuropsychiatry and Clinical Neurosciences. 2002; 14: 223\u201336; discussion 222.","DOI":"10.1176\/jnp.14.2.223"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Mostofi A, Morgante F, Edwards MJ, Brown P, Pereira EAC. Pain in Parkinson\u2019s disease and the role of the subthalamic nucleus. Brain: a Journal of Neurology. 2021; 144: 1342\u20131350.","DOI":"10.1093\/brain\/awab001"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, et al. Pain in Parkinson\u2019s disease: facts and uncertainties. European Journal of Neurology. 2018; 25: 917\u2013e69.","DOI":"10.1111\/ene.13624"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Beiske AG, Loge JH, R\u00f8nningen A, Svensson E. Pain in Parkinson\u2019s disease: Prevalence and characteristics. Pain. 2009; 141: 173\u2013177.","DOI":"10.1016\/j.pain.2008.12.004"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ha AD, Jankovic J. Pain in Parkinson\u2019s disease. Movement Disorders. 2012; 27: 485\u2013491.","DOI":"10.1002\/mds.23959"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Benarroch EE. Descending monoaminergic pain modulation: bidirectional control and clinical relevance. Neurology. 2008; 71: 217\u2013221.","DOI":"10.1212\/01.wnl.0000318225.51122.63"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Pertovaara A. Noradrenergic pain modulation. Progress in Neurobiology. 2006; 80: 53\u201383.","DOI":"10.1016\/j.pneurobio.2006.08.001"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Pagonabarraga J, Tinazzi M, Caccia C, Jost WH. The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson\u2019s disease: Clinical cases and a review of the literature. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia. 2021; 90: 178\u2013183.","DOI":"10.1016\/j.jocn.2021.05.056"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Borsook D, Upadhyay J, Chudler EH, Becerra L. A key role of the basal ganglia in pain and analgesia\u2013insights gained through human functional imaging. Molecular Pain. 2010; 6: 27.","DOI":"10.1186\/1744-8069-6-27"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain. 1995; 60: 3\u201338.","DOI":"10.1016\/0304-3959(94)00172-B"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Buhmann C, Wrobel N, Grashorn W, Fruendt O, Wesemann K, Diedrich S, et al. Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy. Journal of Neurology. 2017; 264: 758\u2013769.","DOI":"10.1007\/s00415-017-8426-y"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, et al. Effect of levodopa on pain threshold in Parkinson\u2019s disease: a clinical and positron emission tomography study. Movement Disorders: Official Journal of the Movement Disorder Society. 2005; 20: 1557\u20131563.","DOI":"10.1002\/mds.20629"},{"key":"ref13","unstructured":"Jenner P, Caccia C. The role of glutamate in the healthy brain and in the pathophysiology of Parkinson\u2019s disease. European Neurological Review. 2019; 14: 2\u201312."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nature Reviews. Neuroscience. 2017; 18: 435\u2013450.","DOI":"10.1038\/nrn.2017.62"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Archives of Neurology. 2003; 60: 1745\u20131748.","DOI":"10.1001\/archneur.60.12.1745"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"M\u00fcller MLTM, Bohnen NI. Cholinergic dysfunction in Parkinson\u2019s disease. Current Neurology and Neuroscience Reports. 2013; 13: 377.","DOI":"10.1007\/s11910-013-0377-9"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Bern\u00e1cer J, Prensa L, Gim\u00e9nez-Amaya JM. Cholinergic interneurons are differentially distributed in the human striatum. PLoS ONE. 2007; 2: e1174.","DOI":"10.1371\/journal.pone.0001174"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Naser PV, Kuner R. Molecular, Cellular and Circuit Basis of Cholinergic Modulation of Pain. Neuroscience. 2018; 387: 135\u2013148.","DOI":"10.1016\/j.neuroscience.2017.08.049"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007; 55: 377\u2013391.","DOI":"10.1016\/j.neuron.2007.07.012"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Picillo M, Nicoletti A, Fetoni V, Garavaglia B, Barone P, Pellecchia MT. The relevance of gender in Parkinson\u2019s disease: a review. Journal of Neurology. 2017; 264: 1583\u20131607.","DOI":"10.1007\/s00415-016-8384-9"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zambito Marsala S, Tinazzi M, Vitaliani R, Recchia S, Fabris F, Marchini C, et al. Spontaneous pain, pain threshold, and pain tolerance in Parkinson\u2019s disease. Journal of Neurology. 2011; 258: 627\u2013633.","DOI":"10.1007\/s00415-010-5812-0"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, et al. King\u2019s Parkinson\u2019s disease pain scale, the first scale for pain in PD: An international validation. Movement Disorders: Official Journal of the Movement Disorder Society. 2015; 30: 1623\u20131631.","DOI":"10.1002\/mds.26270"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Chen K, Yang YJ, Liu FT, Li DK, Bu LL, Yang K, et al. Evaluation of PDQ-8 and its relationship with PDQ-39 in China: a three-year longitudinal study. Health and Quality of Life Outcomes. 2017; 15: 170.","DOI":"10.1186\/s12955-017-0742-5"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders: Official Journal of the Movement Disorder Society. 2008; 23: 2129\u20132170.","DOI":"10.1002\/mds.22340"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Trenkwalder C, Kohnen R, H\u00f6gl B, Metta V, Sixel-D\u00f6ring F, Frauscher B, et al. Parkinson\u2019s disease sleep scale\u2013validation of the revised version PDSS-2. Movement Disorders: Official Journal of the Movement Disorder Society. 2011; 26: 644\u2013652.","DOI":"10.1002\/mds.23476"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008; 31: 1601\u20131607.","DOI":"10.1093\/sleep\/31.11.1601"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occupational Medicine (Oxford, England). 2015; 65: 601.","DOI":"10.1093\/occmed\/kqv054"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"HAMILTON M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry. 1960; 23: 56\u201362.","DOI":"10.1136\/jnnp.23.1.56"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Zambito-Marsala S, Erro R, Bacchin R, Fornasier A, Fabris F, Lo Cascio C, et al. Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials. Parkinsonism & Related Disorders. 2017; 34: 43\u201348.","DOI":"10.1016\/j.parkreldis.2016.10.019"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, Rascol O, et al. Levodopa raises objective pain threshold in Parkinson\u2019s disease: a RIII reflex study. Journal of Neurology, Neurosurgery, and Psychiatry. 2007; 78: 1140\u20131142.","DOI":"10.1136\/jnnp.2007.120212"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Schestatsky P, Kumru H, Valls-Sol\u00e9 J, Valldeoriola F, Marti MJ, Tolosa E, et al. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology. 2007; 69: 2162\u20132169.","DOI":"10.1212\/01.wnl.0000295669.12443.d3"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Wasner G, Deuschl G. Pains in Parkinson disease\u2013many syndromes under one umbrella. Nature Reviews. Neurology. 2012; 8: 284\u2013294.","DOI":"10.1038\/nrneurol.2012.54"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"N\u00e8gre-Pag\u00e8s L, Regragui W, Bouhassira D, Grandjean H, Rascol O, DoPaMiP Study Group. Chronic pain in Parkinson\u2019s disease: the cross-sectional French DoPaMiP survey. Movement Disorders: Official Journal of the Movement Disorder Society. 2008; 23: 1361\u20131369.","DOI":"10.1002\/mds.22142"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008; 70: 1630\u20131635.","DOI":"10.1212\/01.wnl.0000282763.29778.59"},{"key":"ref35","unstructured":"Ford B. Pain in Parkinson\u2019s disease. Clinical Neuroscience (New York, N.Y.). 1998; 5: 63\u201372."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Loeser JD, Treede RD. The Kyoto protocol of IASP Basic Pain Terminology. Pain. 2008; 137: 473\u2013477.","DOI":"10.1016\/j.pain.2008.04.025"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Ford B. Pain in Parkinson\u2019s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2010; 25: S98\u2013S103.","DOI":"10.1002\/mds.22716"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson\u2019s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 1986; 1: 45\u201349.","DOI":"10.1002\/mds.870010106"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Edinoff A, Sathivadivel N, McBride T, Parker A, Okeagu C, Kaye AD, et al. Chronic Pain Treatment Strategies in Parkinson\u2019s Disease. Neurology International. 2020; 12: 61\u201376.","DOI":"10.3390\/neurolint12030014"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Cattaneo C, Barone P, Bonizzoni E, Sardina M. Effects of Safinamide on Pain in Fluctuating Parkinson\u2019s Disease Patients: A Post-Hoc Analysis. Journal of Parkinson\u2019s Disease. 2017; 7: 95\u2013101.","DOI":"10.3233\/JPD-160911"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Cattaneo C, Kulisevsky J, Tubazio V, Castellani P. Long-term Efficacy of Safinamide on Parkinson\u2019s Disease Chronic Pain. Advances in Therapy. 2018; 35: 515\u2013522.","DOI":"10.1007\/s12325-018-0687-z"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Geroin C, Di Vico IA, Squintani G, Segatti A, Bovi T, Tinazzi M. Effects of safinamide on pain in Parkinson\u2019s disease with motor fluctuations: an exploratory study. Journal of Neural Transmission (Vienna, Austria: 1996). 2020; 127: 1143\u20131152.","DOI":"10.1007\/s00702-020-02218-7"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Santos Garc\u00eda D, Y\u00e1\u00f1ez Ba\u00f1a R, Labandeira Guerra C, Cimas Hernando MI, Cabo L\u00f3pez I, Paz Gonz\u00e1lez JM, et al. Pain Improvement in Parkinson\u2019s Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study. Journal of Personalized Medicine. 2021; 11: 798.","DOI":"10.3390\/jpm11080798"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Buhmann C, Kassubek J, Jost WH. Management of pain in Parkinson\u2019s disease. Journal of Parkinson\u2019s Disease. 2020; 10: S37\u2013S48.","DOI":"10.3233\/JPD-202069"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Poewe WH, Lees AJ, Stern GM. Dystonia in Parkinson\u2019s disease: clinical and pharmacological features. Annals of Neurology. 1988; 23: 73\u201378.","DOI":"10.1002\/ana.410230112"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Fil A, Cano-de-la-Cuerda R, Mu\u00f1oz-Hell\u00edn E, Vela L, Ramiro-Gonz\u00e1lez M, Fern\u00e1ndez-de-Las-Pe\u00f1as C. Pain in Parkinson disease: a review of the literature. Parkinsonism & Related Disorders. 2013; 19: 285\u201394; discussion 285.","DOI":"10.1016\/j.parkreldis.2012.11.009"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Del Sorbo F, Albanese A. Clinical management of pain and fatigue in Parkinson\u2019s disease. Parkinsonism & Related Disorders. 2012; 18: S233\u2013S236.","DOI":"10.1016\/S1353-8020(11)70071-2"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Kidron D, Melamed E. Forms of dystonia in patients with Parkinson\u2019s disease. Neurology. 1987; 37: 1009\u20131011.","DOI":"10.1212\/WNL.37.6.1009"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, Moretto G, et al. Pain and motor complications in Parkinson\u2019s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2006; 77: 822\u2013825.","DOI":"10.1136\/jnnp.2005.079053"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Tolosa E, Compta Y. Dystonia in Parkinson\u2019s disease. Journal of Neurology. 2006; 253: 7\u201313.","DOI":"10.1007\/s00415-006-7003-6"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Sophie M, Ford B. Management of pain in Parkinson\u2019s disease. CNS Drugs. 2012; 26: 937\u2013948.","DOI":"10.1007\/s40263-012-0005-2"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Lees AJ. Dopamine agonists in Parkinson\u2019s disease: a look at apomorphine. Fundamental & Clinical Pharmacology. 1993; 7: 121\u2013128.","DOI":"10.1111\/j.1472-8206.1993.tb00226.x"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Kim HJ, Jeon BS, Paek SH. Effect of deep brain stimulation on pain in Parkinson disease. Journal of the Neurological Sciences. 2011; 310: 251\u2013255.","DOI":"10.1016\/j.jns.2011.06.021"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G. \u201dOff\u201d painful dystonia in Parkinson\u2019s disease treated with botulinum toxin. Movement Disorders: Official Journal of the Movement Disorder Society. 1995; 10: 333\u2013336.","DOI":"10.1002\/mds.870100317"},{"key":"ref55","unstructured":"Thomas A, Iacono D, Luciano AL, Armellino K, Di Iorio A, Onofrj M. Duration of amantadine benefit on dyskinesia of severe Parkinson\u2019s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2004; 75: 141\u2013143."},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Broetz D, Eichner M, Gasser T, Weller M, Steinbach JP. Radicular and nonradicular back pain in Parkinson\u2019s disease: a controlled study. Movement Disorders: Official Journal of the Movement Disorder Society. 2007; 22: 853\u2013856.","DOI":"10.1002\/mds.21439"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Rajabally YA, Martey J. Neuropathy in Parkinson disease: prevalence and determinants. Neurology. 2011; 77: 1947\u20131950.","DOI":"10.1212\/WNL.0b013e31823a0ee4"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Marandi MY, Ayromlou H, Najmi S, Sadat-Ebrahimi SR, Pezeshki Z, Asadi R. Prevalence of Levodopa-Induced Peripheral Neuropathy in Patients with Parkinson\u2019s Disease and Vitamin B12 Deficiency. Galen Medical Journal. 2021; 10: e1837\u2013e1837.","DOI":"10.31661\/gmj.v10i0.1837"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Buhmann C, Ip CW, Oehlwein C, T\u00f6nges L, Wolz M, Reichmann H, et al. Parkinson Disease and Pain - diagnostic and therapeutic approaches to a challenging non-motor symptom. Fortschritte Der Neurologie-Psychiatrie. 2018; 86: S48\u2013S58.","DOI":"10.1055\/a-0590-4464"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson\u2019s disease. Clinical Neurology and Neurosurgery. 2011; 113: 11\u201313.","DOI":"10.1016\/j.clineuro.2010.07.024"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Szok D, Tajti J, Ny\u00e1ri A, V\u00e9csei L. Therapeutic Approaches for Peripheral and Central Neuropathic Pain. Behavioural Neurology. 2019; 2019: 8685954.","DOI":"10.1155\/2019\/8685954"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Skogar O, Lokk J. Pain management in patients with Parkinson\u2019s disease: challenges and solutions. Journal of Multidisciplinary Healthcare. 2016; 9: 469\u2013479.","DOI":"10.2147\/JMDH.S105857"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Comella CL, Goetz CG. Akathisia in Parkinson\u2019s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 1994; 9: 545\u2013549.","DOI":"10.1002\/mds.870090507"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Ha AD, Jankovic J. Pain in Parkinson\u2019s disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2012; 27: 485\u2013491.","DOI":"10.1002\/mds.23959"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Lang AE, Johnson K. Akathisia in idiopathic Parkinson\u2019s disease. Neurology. 1987; 37: 477\u2013481.","DOI":"10.1212\/WNL.37.3.477"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Ferry P, Johnson M, Wallis P. Use of complementary therapies and non-prescribed medication in patients with Parkinson\u2019s disease. Postgraduate Medical Journal. 2002; 78: 612\u2013614.","DOI":"10.1136\/pmj.78.924.612"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Qureshi AR, Jamal MK, Rahman E, Paul DA, Oghli YS, Mulaffer MT, et al. Non-pharmacological therapies for pain management in Parkinson\u2019s disease: A systematic review. Acta Neurologica Scandinavica. 2021; 144: 115\u2013131.","DOI":"10.1111\/ane.13435"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Gandolfi M, Geroin C, Antonini A, Smania N, Tinazzi M. Understanding and Treating Pain Syndromes in Parkinson\u2019s Disease. International Review of Neurobiology. 2017; 134: 827\u2013858.","DOI":"10.1016\/bs.irn.2017.05.013"}],"container-title":["Journal of Integrative Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/22\/5\/10.31083\/j.jin2205132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:13:22Z","timestamp":1732724002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/22\/5\/10.31083\/j.jin2205132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"alternative-id":["S0219-6352(23)00600-9"],"URL":"https:\/\/doi.org\/10.31083\/j.jin2205132","relation":{},"ISSN":["0219-6352","1757-448X"],"issn-type":[{"value":"0219-6352","type":"print"},{"value":"1757-448X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"article-number":"132"}}